Article actualité
Plus d'articles...
- NH TherAguix announces the arrival of Dr. Olivier de Beaumont as Chief Medical Officer
- Neuroplast receives second orphan medicinal product designation for Neuro-Cells®, paving the way for application to both chronic and trauma-induced neurodegenerative diseases
- Muvon Therapeutics Announces Successful Phase I Clinical Study in Female Patients with Stress Urinary Incontinence using a Novel Regenerative Cell Therapy
- Adocia : preuve de concept préclinique sur AdoShell® Islets dans le diabète de type 1 par thérapie cellulaire